New kidney drug candidate SK-09 enters first human safety tests

This early-stage study is testing a new oral drug called SK-09 in 72 healthy adults to see if it is safe and how the body processes it. The study is split into two parts: one where participants get a single dose, and another where they get multiple doses. No one knows who gets the drug or a placebo. This research is a first step before testing the drug in people with kidney diseases like FSGS and MCD.